Risk Factors Update Summary
- Loss of "smaller reporting company" status increases legal and financial compliance costs significantly.
- The CARES Act extended the Medicare reimbursement rate to 75% adjusted fee schedule and 25% unadjusted fee schedule, expiring on December 31, 2023.
- Philips Respironics' decision to discontinue respiratory products exacerbates dependence on key suppliers.
- Revenue sources shifted with 10% more derived from managed care plans and 10% less from Medicare/Medicaid.
- Future rounds of HIPAA regulations may impact approximately 8% of total traditional revenue.
- Plans to retain earnings for business operations indicate no near-term cash dividends for investors.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1729149&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.